0
Skip to Content
B+ | Fighting Childhood Cancer
ABOUT
ABOUT
OVERVIEW
ANDREW'S STORY
CHILDHOOD CANCER FACTS
FINANCIALS
GET INVOLVED
GET INVOLVED
B+ EVENTS
STUDENTS & SCHOOL EVENTS
INDIVIDUAL EVENTS
B+ HEROES
ALUMNI & PROFESSIONALS
PARTNERS & SPONSORS
INVITE JOE TO SPEAK
WAYS TO GIVE
ANDREW'S CHAMPIONS FOR HOPE
RESEARCH
RESEARCH
OVERVIEW
RESEARCH GRANTS
NEED HELP?
NEED HELP
FAMILY ASSISTANCE
PSYCHOSOCIAL SUPPORTS
TESTIMONIALS
BLOG
MERCH
DONATE
B+ | Fighting Childhood Cancer
ABOUT
ABOUT
OVERVIEW
ANDREW'S STORY
CHILDHOOD CANCER FACTS
FINANCIALS
GET INVOLVED
GET INVOLVED
B+ EVENTS
STUDENTS & SCHOOL EVENTS
INDIVIDUAL EVENTS
B+ HEROES
ALUMNI & PROFESSIONALS
PARTNERS & SPONSORS
INVITE JOE TO SPEAK
WAYS TO GIVE
ANDREW'S CHAMPIONS FOR HOPE
RESEARCH
RESEARCH
OVERVIEW
RESEARCH GRANTS
NEED HELP?
NEED HELP
FAMILY ASSISTANCE
PSYCHOSOCIAL SUPPORTS
TESTIMONIALS
BLOG
MERCH
DONATE
Folder: ABOUT
Back
ABOUT
OVERVIEW
ANDREW'S STORY
CHILDHOOD CANCER FACTS
FINANCIALS
Folder: GET INVOLVED
Back
GET INVOLVED
B+ EVENTS
STUDENTS & SCHOOL EVENTS
INDIVIDUAL EVENTS
B+ HEROES
ALUMNI & PROFESSIONALS
PARTNERS & SPONSORS
INVITE JOE TO SPEAK
WAYS TO GIVE
ANDREW'S CHAMPIONS FOR HOPE
Folder: RESEARCH
Back
RESEARCH
OVERVIEW
RESEARCH GRANTS
Folder: NEED HELP?
Back
NEED HELP
FAMILY ASSISTANCE
PSYCHOSOCIAL SUPPORTS
TESTIMONIALS
BLOG
MERCH
DONATE
HBEGF as a novel therapeutic target for Diffuse Midline Glioma
Northeast, New York Julia Travagline 11/20/24 Northeast, New York Julia Travagline 11/20/24

HBEGF as a novel therapeutic target for Diffuse Midline Glioma

HBEGF as a novel therapeutic target for Diffuse Midline Glioma

Dr. Oren Becher, M.D. – Icahn School of Medicine at Mount Sinai, New York, NY

Read More
The impact of UBTF Tandem Duplications in Pediatric Acute Myeloid Leukemia
New York, Northeast Julia Travagline 11/20/24 New York, Northeast Julia Travagline 11/20/24

The impact of UBTF Tandem Duplications in Pediatric Acute Myeloid Leukemia

The impact of UBTF Tandem Duplications in Pediatric Acute Myeloid Leukemia

Dr. lannis Aifantis, Ph.D. – New York University Grossman School of Medicine, New York, NY

Read More
The Role of S100A8/A9-IL6R in B-ALL Chemoresistance
Northeast, New York Julia Travagline 11/20/24 Northeast, New York Julia Travagline 11/20/24

The Role of S100A8/A9-IL6R in B-ALL Chemoresistance

The Role of S100A8/A9-IL6R in B-ALL Chemoresistance

Dr. William Carroll, M.D. – New York University Grossman School of Medicine, New York, NY

Read More
Preclinical evaluation of BRD inhibitors to treat Posterior Fossa A ependymoma
Northeast, New York Julia Travagline 11/22/23 Northeast, New York Julia Travagline 11/22/23

Preclinical evaluation of BRD inhibitors to treat Posterior Fossa A ependymoma

Preclinical evaluation of BRD inhibitors to treat Posterior Fossa A ependymoma

Dr. Oren Becher – Icahn School of Medicine at Mount Sinai, New York, NY

Read More
Therapeutical reprogramming of DIPG cells
Northeast, New York Julia Travagline 12/14/22 Northeast, New York Julia Travagline 12/14/22

Therapeutical reprogramming of DIPG cells

Therapeutical reprogramming of DIPG cells

Joan & Sanford I. Weill Medical College of Cornell University, New York, NY

Read More
T cell immunotherapy targeting fusion-derived “public” neoantigens expressed by pediatric desmoplastic small round cell tumors
Northeast, New York Julia Travagline 12/8/21 Northeast, New York Julia Travagline 12/8/21

T cell immunotherapy targeting fusion-derived “public” neoantigens expressed by pediatric desmoplastic small round cell tumors

T cell immunotherapy targeting fusion-derived “public” neoantigens expressed by pediatric desmoplastic small round cell tumors

Memorial Sloan Kettering Cancer Center (MSK), New York, NY

Read More
The role of inflammation in the liver microenvironment of a Fibrolamellar Carcinoma zebrafish model
New York, Northeast Julia Travagline 12/8/21 New York, Northeast Julia Travagline 12/8/21

The role of inflammation in the liver microenvironment of a Fibrolamellar Carcinoma zebrafish model

The role of inflammation in the liver microenvironment of a Fibrolamellar Carcinoma zebrafish model

Albert Einstein College of Medicine, New York, NY

Read More
Arginine methylation as a potential therapeutic target in high-risk neuroblastoma
New York, Northeast Julia Travagline 8/10/21 New York, Northeast Julia Travagline 8/10/21

Arginine methylation as a potential therapeutic target in high-risk neuroblastoma

Arginine methylation as a potential therapeutic target in high-risk neuroblastoma

University of Rochester, Rochester, NY

Read More
Disrupting Neuroblastoma Tumor-Initiating Cells
New York, Northeast Julia Travagline 8/9/21 New York, Northeast Julia Travagline 8/9/21

Disrupting Neuroblastoma Tumor-Initiating Cells

Disrupting Neuroblastoma Tumor-Initiating Cells

University of Rochester, Rochester, NY

Read More
Tumorigenesis of a Pediatric Liver Cancer
New York, Northeast Julia Travagline 8/9/21 New York, Northeast Julia Travagline 8/9/21

Tumorigenesis of a Pediatric Liver Cancer

Tumorigenesis of a Pediatric Liver Cancer

The Rockefeller University, New York, NY

Read More

HELPFUL LINKS

BLOG

RESEARCH

SCHOOLS

COMPANIES

FACTS

PRIVACY

ABOUT

B+ EVENTS

B+ HEROES

HERO FUNDS

B+ GEAR

GET ASSISTANCE

 

CONNECT WITH US

Address: The B+ Foundation
101 Rockland Circle
Wilmington, DE 19803

Phone: 302.563.8389 | 845.304.6347
Email: Joe@BePositive.org | Carly@BePositive.org

Family Assistance: Katie@BePositive.org | 609.330.6775

 
Today-logo.png
 
ICRP-logo copy.jpg
 

CONTACT US

Name *
Thank you!

 The Andrew McDonough B+ Foundation is an IRS-certified 501(c)3 organization. Our Tax ID # is 42-1741037.

B+® is a registered trademark